Clinical White Papers

IQ•SPECT™ delivers fast myocardial perfusion imaging (MPI) with similar diagnostic confidence to low-energy high-resolution (LEHR), but with the advantage of high acquisition speed as well as the possibility of integrated diagnostic CT-based attenuation correction. This white paper briefly explains the technical aspects of IQ•SPECT and demonstrates normal patterns and variations, as well as shows a series of clinical examples of ischemia and infarction to familiarize nuclear cardiologists with IQ•SPECT.

Major advances in SPECT/CT technology have enabled absolute quantification to be accurate and reproducible. Download the white paper and explore the clinical impact of SPECT/CT quantification in theranostics and dosimetry.

PET/CT plays an increasingly important role in the appropriate clinical setting in both initial and subsequent treatment strategies in melanoma management. Read the white paper to discover the value PET/CT imaging can have for melanoma.

Skeletal scintigraphy has been a mainstay of nuclear medicine for decades. Take a closer look at clinical examples that illustrate the image quality levels in bone scintigraphy made possible using xSPECT Bone™ technology in this SPECT/CT clinical white paper.

The introduction of xSPECT Quant™ for absolute quantification of ¹⁷⁷Lu, ¹¹¹In, and ¹²³I is a major step toward implementation and expansion of standardized evidence-based medicine in the realm of radionuclide imaging. Download the white paper to learn more about Siemens Healthineers’ xSPECT Quant technology.

In 2013, Siemens introduced xSPECT™, which represents a more complete integration of SPECT and CT data. Download the white paper to understand the fundamentals of xSPECT reconstruction for SPECT/CT and its advantages over traditional approaches.

Discover how transitioning from a mobile PET scanner—an ideal way to introduce technology to facilities interested in exploring the potential for PET imaging— to a fixed scanner can benefit in a hospital setting.

Learn how PET/CT provides metabolic and morphological information, which has a major impact on the evaluation and therapy planning of primary and recurrent lung tumors.

PET/CT is a powerful modality used to assess cervical cancer, particularly in tumors of stage IB and beyond. As the topic of cervical cancer and PET/CT has been increasing in interest in the last years, stay informed on the status of the disease, guidelines, and reimbursement opportunities by reading the following white paper.

Explore the role of PET/CT in imaging high-risk patients (such as those with an elevated PSA level or Gleason score) for skeletal metastases. Read the white paper to review PET's role on therapy decisions during initial diagnosis and therapy monitoring.

PET/CT plays an increasing role in breast cancer staging, treatment, and follow-up. Discover how new technical developments in PET scanner technologies might additional contribute to strengthening and expanding the role of clinical PET/CT in breast cancer care.